W aktualnym wydaniu czasopisma Ophthalmology AAO znalazły się artykuły oryginalne, w tym m.in.:

  • Ocular Inflammation as a Risk Factor for Antiadalimumab Antibodies in Patients with Autoimmune Diseases Treated with Adalimumab
  • Optimizing Anti-Tumor Necrosis Factor Inhibitor Therapy in Uveitis: Looking beyond Treatment Failure
  • Efficacy of Diversified Segmental Defocus Optimization Lenses on Axial Length Growth in Children and Adolescents with or without Myopia
  • The Emerging Faces of Myopia Management: Staying Evident
  • Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years
  • Not Just for Retinal Specialists? Intravitreal Bevacizumab in Glaucoma Surgery
  • Semaglutide and Neovascular Age-Related Macular Degeneration among Adults with Type 2 Diabetes
  • Glucagon-Like Peptide-1 Receptor Agonist and Age-related Macular Degeneration: Adding to the Story
  • Modifiable Factors Associated with Diabetic Retinal Disease and Retinal Neural Layer Thickness in Youth with Type 1 Diabetes
  • Understanding the Neurodegenerative Changes in Diabetic Retinal Disease
  • Early Optic Nerve Head Swelling Rate Is Associated with Worsening of Visual Outcomes in Nonarteritic Anterior Ischemic Optic Neuropathy
  • Can We Stratify Risk of Vision Worsening after Onset of Acute Nonarteritic Anterior Ischemic Optic Neuropathy?

Dostęp do artykułów możliwy jest pod linkiem:  https://www.aaojournal.org/current

Zachęcamy do lektury.